202198-18-3 Usage
Uses
Used in Pharmaceutical Industry:
N-Methyl-2-(methylsulfonyl)ethylamine is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its nucleophilic nature allows it to participate in numerous chemical reactions, facilitating the production of a broad spectrum of medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, N-Methyl-2-(methylsulfonyl)ethylamine serves as an essential intermediate for the development of agrochemicals. Its ability to undergo various chemical transformations makes it a valuable component in the creation of compounds used in agricultural applications.
Used in Specialty Chemicals Industry:
N-Methyl-2-(methylsulfonyl)ethylamine is employed as a building block in the synthesis of specialty chemicals. Its versatility in chemical reactions contributes to the production of a wide range of specialty compounds used in specific industrial applications.
Used in Chemical Synthesis:
As a nucleophilic agent, N-Methyl-2-(methylsulfonyl)ethylamine is used in various chemical synthesis processes. Its capacity to engage in multiple types of reactions makes it instrumental in the production of a diverse array of chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 202198-18-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,1,9 and 8 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 202198-18:
(8*2)+(7*0)+(6*2)+(5*1)+(4*9)+(3*8)+(2*1)+(1*8)=103
103 % 10 = 3
So 202198-18-3 is a valid CAS Registry Number.
202198-18-3Relevant academic research and scientific papers
Indazole-carboxamide compounds
-
Page/Page column 22, (2008/06/13)
The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Synthesis and SAR of potent EGFR/erbB2 dual inhibitors
Zhang, Yue-Mei,Cockerill, Stuart,Guntrip, Stephen B.,Rusnak, David,Smith, Kathryn,Vanderwall, Dana,Wood, Edgar,Lackey, Karen
, p. 111 - 114 (2007/10/03)
A series of 6-alkoxy-4-anilinoquinazoline compounds was prepared and evaluated for in vitro inhibition of the erbB2 and EGFR kinase activity. The IC50 values of the best compounds were below 0.10 uM. Further, several of these compounds inhibit the growth of erbB2 and EGFR over-expressing tumor cell lines at concentrations below 1 uM.
